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Previous studies in our laboratory have shown that interstitial laser thermotherapy (ILT) of an experimental liver tumour is superior
to surgical excision, at least partly due to a laser-induced immunological effect. The aim of the present study was to investigate the
time–response relationship of the ILT-induced immunisation and the cellular response of macrophages and lymphocytes. A
dimethylhydrazine-induced adenocarcinoma was transplanted into the liver of syngeneic rats. Rats with tumour were treated 6–8
days later (tumour size 0.25–0.40cm
3) with ILT of tumour or resection of the tumour-bearing lobe. Two groups of rats without
tumour were treated with resection of a normal liver lobe or ILT of normal liver. A challenging tumour was implanted into the liver of
each rat 2, 5 or 10 weeks after primary treatment. Rats were killed 6, 12 and 48 days (or earlier due to their condition) after challenge
(n¼8 in all groups). Immunohistochemical techniques were used to determine lymphocytes (CD8, CD4) and macrophages (ED1,
ED2) in rats having had treatment of a primary tumour. Interstitial laser thermotherapy of the first tumour was followed by
eradication of challenging tumour and absence of tumour spread. This contrasted with rapid growth and spread of challenging tumour
in the other groups. In the challenging vital tumour tissue and in the interface between the tumour and surroundings, the number of
ED1 macrophages and CD8 lymphocytes was higher in rats having been treated with the ILT of tumour than in those having
undergone resection of the tumour-bearing lobe. The number of ED2 macrophages and CD4 lymphocytes was low and did not vary
between these two groups. Interstitial laser thermotherapy elicited an immune response that eradicated a challenging tumour and
was associated with increased numbers of tumour-infiltrating macrophages and CD8 lymphocytes.
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In the future, curative treatment of solid tumours is likely to
consist of local treatment (surgical excision or some form of local
tissue destruction) coupled with different types of adjuvant
therapy. The reason why local excision alone may not be sufficient
for cure is the risk for occult disseminated disease and, also, the
risk for local recurrence. Surgery is known to induce immuno-
suppression and the release of growth factors that may stimulate
growth of residual tumour (discussed in Mo ¨ller et al, 1998). The
reason why systemic therapy like chemotherapy or immunother-
apy is likely to be insufficient as the sole treatment is their relative
inefficacy for solid tumours and the fact that clinical tumour
burdens are large. As for immunotherapy, possible success appears
to depend on combination with procedures that give efficient
tumour killing and antigen exposure. Heating of tumour cells with
interstitial laser thermotherapy (ILT) is interesting in this respect,
since it can accomplish total local tumour destruction by tumour
necrosis at the same time as it induces an immunological response
against the tumour (Mo ¨ller et al, 1998; Tranberg et al, 2002).
Using a model of adenocarcinoma implanted into rat liver, we
reported that ILT gave results that were superior to those of
surgical resection of the tumour-bearing liver lobe (Mo ¨ller et al,
1998). The efficacy of local tumour removal was similar, but the
ILT method was associated with less extrahepatic spread. Evidence
for a laser-induced immunological effect was then obtained by the
following study. Using inoculation of tumour cell suspensions into
the lateral and median lobes of the liver simultaneously and
treating the lateral lobe tumour only, we found that laser
thermotherapy reduced take and growth of the untreated tumour
in the median lobe. This twin tumour study thus provided direct
evidence that the advantageous effect of ILT can at least partly be
explained by the induction of an immunological response
(Tranberg et al, 2002).
The aim of the present study was to examine the time–response
relationship of the ILT-induced immunisation and to elucidate the
possible mechanisms by studying tissue densities of macrophages
and CD4 and CD8 lymphocytes.
MATERIAL AND METHODS
Animals and tumour
The experiments were performed with male rats from Møllegaard
A/S (Ejby, Denmark), but complementary studies were performed
with Wistar FU from our own breeding. Rats weighed 224–292g at
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sthe time of tumour implantation. They were housed individually
and had free access to standard food pellets (Ewos R3; Lactamin AB,
So ¨derta ¨lje, Sweden) and tap water ad libitum. The tumour was a
dimethylhydrazine-induced, weakly immunogenic adenocarcinoma
of the rat colon obtained from the Wallenberg Research Laboratory,
Lund (Steele and Sjo ¨gren, 1974). The tumour was propagated by
weekly intraperitoneal passages in inbred Wistar rats from our own
breeding. Generations 140–154 were used in this study.
Tumour implantation was performed with vital and macro-
scopically homogenous tumour. At midline laparatomy and using
an operating microscope (Olympus OMK 1, Olympus Optical,
Tokyo, Japan), a 3-mm-long and 2-mm-deep incision was made on
the anterior surface of the liver. A piece of Spongostan (Ferrosan
A/S, Søborg, Denmark) was applied to the incision area for 5min
to control bleeding. A piece of the tumour (1.0mm in diameter)
was then implanted into the parenchyma, followed by application
of Spongostan for another 2min. The first tumour (the tumour to
be treated) was implanted into the left lateral lobe of the liver,
whereas the second (challenging) tumour was implanted into the
median lobe of the liver. Tumour preparations were made
immediately before transplantation and were kept on ice cubes
until implanted.
Rats were anaesthetised with an intraperitoneal injection of 5%
chloral hydrate (0.5mg per 100g body weight) for tumour
implantation. Ether was used for all other procedures that required
anaesthesia, including treatments, challenges and euthanasia. All
treatments were performed using a midline abdominal incision.
Treatment procedures were followed by intramuscular injection of
buprenorphine (Temgesic, Meda AB, Go ¨teborg, Sweden), 0.002mg
per 100g body weight, for analgesia.
Animal procedures were performed according to the recom-
mendations of the Swedish Board of Animal Research and were
approved by the Committee of Animal Ethics at Lund University.
Experimental protocol
We used 288 rats which were randomly allocated to four groups.
Two groups of rats with tumour (I–II) were treated with ILT of
tumour (I) or resection of the tumour-bearing lobe (II). Two
groups of rats without tumour (III–IV) were treated with resection
of a normal liver lobe (III) or ILT of normal liver (IV). Treatment
of rats with tumour (I–II) was performed 6–8 days after
implantation, at which time tumour had a size of 140725
(mean7s.e.m.)mm
3 and did not vary between the treatment
groups (P40.05). A challenging tumour was implanted into the
liver of each rat 2, 5 or 10 weeks after primary treatment (groups
I–IV). Rats were planned to be killed 6, 12 and 48 days after
challenge (n¼8 in all groups). However, rats were euthanised as
soon as they showed signs of inactivity or distress. At that time,
there was usually palpable intraabdominal tumours.
After killing, the liver, lungs, peritoneum and all tissues
containing suspect tumour growth were harvested for microscopic
examination. Immunohistochemical examinations were carried
out after challenge in rats having had treatment of a primary
tumour (groups I–II).
Interstitial laser thermotherapy (ILT)
Thermotherapy was carried out with a system consisting of an
Nd:YAG laser and a temperature feedback control unit interfaced
with the laser, as described in detail elsewhere (Mo ¨ller et al, 1996,
1997, 1998) (Figure 1). The laser beam was delivered through a
600-mm flexible bare fibre at a laser output power of 2W. The bare
fibre was placed at right angles into the centre of the tumour, at a
depth measuring one-third of the thickness of the liver, including
the tumour. A feedback thermistor probe (Microtherm AB, Lund,
Sweden) was placed perpendicularly into the liver parenchyma at a
distance of 3mm from the tumour margin and at a depth of 2mm
from the liver surface. The distance from the tip of the bare fibre to
the thermistor probe averaged 6.470.1 (mean7s.e.m.)mm.
Interstitial laser thermotherapy was performed at a steady-state
target temperature of 461C for 30min at the thermistor probe, that
is, 3mm from the tumour margin. The treatment characteristics
were based on previous studies defining the temperature and
duration of treatment needed for complete tumour necrosis, as
judged 6 days after treatment (Mo ¨ller et al, 1996, 1997, 1998).
Interstitial laser thermotherapy of normal liver was performed in
the same way, using the distance between the laser fibre and
thermistor probe found in rats with tumours.
Resectional procedures
Resection of the tumour-bearing, or normal, left lateral lobe was
performed after division of the falciform ligament and the
triangular plicae on the left side. A ligature of 4-0 Suturamid
(Johnson and Johnson AB, Sweden) was tied around the most
central part of the venous and arterial pedicle to the left lateral
liver lobe. The liver was transected with a pair of scissors 1–2mm
distal to the ligature and 10.370.4 (mean7s.e.m., range 7.0–
15.0)mm proximal to the tumour, as measured macroscopically. A
soft gauze was carefully placed under the left lateral liver lobe in
order to collect possible bleeding from the resection line.
Histopathology
Liver tissues were fixed in 4% paraformaldehyde in 0.1 M sodium
phosphate buffer (PB) as a rule for 24h. The livers with tumours
were delivered uncut to the pathologist, who examined the
specimens while unaware of the treatment. A section was cut
through what was considered to be the largest diameter of the
lesion(s), sometimes supplemented with one or two additional
sections. The specimens were then rinsed, dehydrated and
embedded in paraffin. After sectioning, the slides were processed
for immunohistochemistry or stained with haematoxylin/eosin.
The sizes of total tumour and necrotic tumour were measured
under the microscope with a micrometer, because it was
impossible to distinguish necrosis, inflammatory changes and
tumour with the naked eye, especially in rats that had been treated
with laser thermotherapy.
Immunohistochemistry
The sections were deparaffinised with xylene and brought to 96%
alcohol and washed in 0.1 M sodium phosphate-buffered saline
Figure 1 Schematic illustration of feedback temperature system for ILT.
ATS, automatic thermometry system; PC, personal computer.
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s(PBS) with 0.25% Triton X-100, pH 7.2. Immunohistochemical
reaction for tissue macrophages was performed with ED1 and ED2
mouse anti-rat antibodies (diluted 1:200) (Serotec Ltd, Oxford,
UK), using a secondary rabbit anti-mouse antibody (Dijkstra et al,
1985; Damoiseaux et al 1994). Reaction for CD4 and CD8 was
performed with mouse anti-rat antibodies (diluted 1:200) (Nordic
Biosite AB, Ta ¨by, Sweden), using a secondary rabbit anti-mouse
antibody (Whiteland et al, 1995). Visualisation was performed
with diaminobenzidine (DAB) (Saveen Biotech AB, Malmo ¨,
Sweden) (brown colour). Counterstaining was made with haema-
toxylin ad modum Mayer. Negative controls (buffer instead of
primary antibody) were performed to each reaction.
Labelled cells were counted per visual field with an  40
objective and an  10 ocular. As a rule, only whole fields were
counted on peripheral vital tumour and granulation tissue. It was
tried to count six fields for each type of tissue, but that was not
always possible. For each rat, ED1, ED2, CD4 and CD8 slides were
counted one after the other to ensure that the same areas were
counted with all antibodies. The order of examination of slides
varied. Necroses and large vessels were avoided. The mean per
visual field was used in the statistical analysis.
Calculations
Lesion size (V) was estimated according to the formula V¼a 
b
2/2, where a is the largest width and b is the maximum diameter
perpendicular to the width of the tumour (Carlsson et al, 1983).
Before treatment, these measurements, including measurement of
the liver thickness, were performed during laparotomy using a
vernier caliper.
The significance of differences between groups was assessed
with the Mann–Whitney test. Values are means7s.e.m. Prob-
abilities of less than 0.05 were accepted as significant.
RESULTS
The tumour is a poorly differentiated carcinoma growing
expansively in the liver without or with very little tissue reaction
from the host. Tumours that were treated with resection had
irregular necroses in the centre and were proliferating in the
periphery with a rather smooth boundary to the surrounding liver
tissue without inflammatory reaction, except for an occasional
small area of granulation tissue. The microscopic changes seen a
week after laser treatment have been described in detail in
previous communications (Mo ¨ller et al, 1996, 1997, 1998). Briefly,
the treated tumour contains cells with faintly stained nuclei and
eosinophilic cytoplasm, as a rule surrounded by a layer of necrotic
liver tissue. In the peripheral parts of the necroses, there are
polymorphonuclear leucocytes and macrophages and a few
lymphocytes.
The growth of challenging liver tumours in groups I–II is
summarised in Table 1. The challenging tumour after ILT of
tumour (group I) was followed by eradication of reimplanted
tumour at 48 days and absence of tumour spread. After 48 days,
there was as a rule only a fibrous scar, included in Table 2 under
‘tumour capsule’, sometimes no remnant at all. This contrasted
with the rapid growth and spread of tumour following implanta-
tion of tumour in the other groups (II–IV), leading to euthanasia
of all animals within 30 days. In two of the ILT animals vital
tumour cells were found at 48 days at immunohistochemistry, but
not in haematoxylin–eosin sections. None of the rats that had
undergone ILT of the first tumour showed evidence of ascites or
extrahepatic spread (group I). All other rats had both extensive
intraperitoneal tumour growth and ascites, with no obvious
differences between rats that had undergone resection of the
tumour-bearing left lateral liver lobe, resection of the normal left
lateral liver lobe and ILT of normal liver (groups II–IV).
With the exception of the ILT animals, the tumours that were
implanted into treated rats had the same appearance as the
tumours that were resected before reimplantation. In rats treated
with ILT, there appeared to be relatively large numbers of
polymorphonuclear leucocytes in the peripheral parts of necrotic
tumour.
The number of ED1 macrophages in tumour capsule and viable
tumour was significantly larger in the ILT (group I) than in the
resection groups (II) at 12 days after challenge (Po0.05 in both
instances). The difference between the ILT and resection groups
was more obvious for CD8 lymphocytes: numbers were larger in
the ILT group both at 6 and 12 days after challenge, and both in the
tumour capsule and in viable tumour (Po0.05 in all instances).
ED2 and CD4 cells were always few, and there were no differences
between the ILT and resection groups (P40.05) (Table 2). There
was often a concentration of ED1 cells in the tumour periphery.
Table 1 Size of challenging tumour after treatment (n¼8 in each group)
Vital tumour at killing (mm
3), days after implantation of
new tumour
Group
Implantation
post-treatment,
weeks 6 days 12 days 48 days
a
I. Interstitial laser thermotherapy (ILT) of tumour 2 34715 201736 1.071.0
b
52 5 75.6 150766 0
10 6.673.4 15714 0
II. Resection of tumour-bearing liver lobe 2 280711 204725 24937405
5 336716 18367249 13217250
10 231744 17877341 17797339
III. Resection of normal liver lobe 2 351733 426781 23727396
5 282725 17417311 23197381
10 354716 22727319 28437365
IV: Interstitial laser thermotherapy (ILT) of normal liver 2 270715 8417196 31177385
5 366748 23817351 33337201
10 267736 1472786 34737372
Values are means7s.e.m.
aRats having been treated with ILT of tumour survived for 48 days after challenge with new tumour. All other rats had to be euthanised within 10–30
days with extensive tumour burden, intraperitoneal spread and ascites; these rats were included in the 48-days column.
bTwo tumours.
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sAs a rule, ED1- and ED2-positive cells had the appearance of
macrophages in vital tumour (Figure 2). In the granulation tissue,
myofibroblast-like cells as well as macrophages were positive for
both ED1 and ED2 antibodies. Generally, more macrophages than
myofibroblast-like cells were positive. The number of macrophages
in granulation tissue should be regarded with some caution, but it
appears that ED1-positive cells should represent mainly macro-
phages in vital tumour tissue.
DISCUSSION
Local tumour therapy with hyperthermia focuses on two different
aspects: (a) atraumatic reduction or ablation of tumour (Tranberg
et al, 1996, 2002; Mo ¨ller et al, 1998; Vogl et al, 1998; Isbert et al,
2002), and (b) induction of tumour immunity, alone or together
with cytokine therapy (Mo ¨ller et al, 1998; Tranberg et al, 2002;
Dranoff, 2004). This study confirmed that laser thermotherapy can
elicit a favourable immunological response at the same time as it
eradicates the primary tumour, and showed that this response
remains strong at least 10 weeks after treatment. It also showed
that laser treatment was followed by an immune cellular response
of tumour-infiltrating macrophages and CD8 lymphocytes.
CD8 lymphocytes and ED1 macrophages invaded the challen-
ging tumour. This agrees with findings in studies in which
antitumour immunity has been induced and where these two cell
types have been found to be of importance (Caruso et al, 1993;
Barba et al, 1994; Consalvo et al, 1995; Yamamoto et al, 1997;
Xiang et al, 1998; Kuriyama et al, 1999a,b). Antitumour immunity
is a complex phenomenon. There is growing evidence that
dendritic cells are important for induction of immunity (Todryk
et al, 1999; Basu et al, 2000; Sauter et al, 2000). Other studies have
suggested that CD4 cells (Caruso et al, 1993; Kuriyama et al,
1999a,b), natural killer cells (Pierrefite-Carle et al, 1999) and
antibodies (Chen et al, 1999) also may play important roles.
Futhermore, it appears that recognition of tumour antigens by T
lymphocytes is not enough for efficient tumour cell killing and for
elimination of the effect of tumour-induced immunosuppression
(Horiguchi et al, 1999). Efficient immune therapy seems to require
a local inflammatory reaction of a certain type coupled with the
secretion of a mixture of appropriate cytokines (Ganss et al, 2002;
Dranoff, 2004). The local presence of cytokines like IL-12, IL-18,
INF-g or TNF-a helps to generate cytolytic effector cells.
Though we and the cited authors have used a syngeneic tumour
model, it can be argued that the tumour was raised a long time ago,
in our system 30 years ago. A genetic drift may have occurred, in
the tumour and/or the rats, and transplantation antigens may have
been responsible, at least in part, for the outcome. However, in our
previous twin tumour study, the same effect was obtained in rats
that were inoculated with a pure tumour cell suspension at two
different sites in the liver (Tranberg et al, 2002), a model that
carries a reduced risk of transplantation antigen involvement. In
addition, we performed experiments also in another breed of the
same syngeneic strain, and were pleased to obtain the same results
Table 2 Density of ED1 and ED2 macrophages and CD4 and CD8 lymphocytes in implanted tumour in treated rats (n¼8 in each group)
ED1-positive
macrophages
a
ED2-positive
macrophages
a CD4 lymphocytes
a CD8 lymphocytes
a
Group
Implantation
post-treatment,
weeks/killing,
days after
challenge
Tumour
capsule
Viable
tumour
Tumor
capsule
Viable
tumour
Tumour
capsule
Viable
tumour
Tumour
capsule
Viable
tumour
I. Interstitial laser
thermotherapy (ILT)
2w/6d 76725 74724 0.270.4 0.871.0 0.870.8 0701 4 78.3* 1577.6*
5w/6d 58714 54719 070 0.670.5 0700 702 7 716* 20722*
10w/6d 65729 79713 0.570.5 0.570.5 — 0.370.5 17723* 9.876.1*
2w/12d 76735* 64729* 0.470.5 — 0.570.9 0702 9 724* 11715*
5w/12d 73719* 73731* 070 0.671.0 0.170.3 0702 0 712* 18715*
10w/12d 62715 65722 1.171.1 0.871.2 1.471.3 0.270.4 12713 26710
2w/48d
b 19723 — 0.370.6 0.570.7 — — 3.374.2 0.570.7
5w/48d 46726 — 070— 0 70 — 1.171.2 —
10w/48d 37712 — 1.071.4 — 1.071.4 — 2.572.1 —
II. Resection of tumour-
bearing liver lobe
2w/6d 77720 73718 0.370.8 0.170.4 0.370.5 0.770.8 13714 1075.2
5w/6d 63713 62712 1.271.6 1.570.8 0700 701 7 716 2.373.4
10w/6d 91720 89729 0.2570.5 1.071.4 0.570.6 0.670.5 1175.9 1477.8
2w/12d 64725 54729 0.971.6 0.470.5 0700 701 4 712 1278.6
5w/12d 58714 49713 0.370.5 0.270.4 0.270.4 0.270.4 1778.4 11710
10w/12d — — — — — — — —
2w/48d
c ————————
5w/48d
c 25721 0 1.071.7 1.071.4 1.071.4 1.071.4 1.371.1 070
10w/48d
c ————————
w¼weeks; d¼days.
aNumber of cells per visual field.
bTwo rats with signs of vital tumour in the liver.
cAnimals had to be euthanised 10–30 days after reimplantation and only
two tumours were analysed. Values are means7s.e.m. *Po0.05 for comparisons between ILT and resection of tumour-bearing liver lobe. For comparison between treatments,
values were pooled for each post-treatment challenge day, since there were no differences within each day for different weeks after treatment.
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s(data not shown). It would be of considerable interest to examine
two quite different tumours in the same animal strain with similar
or identical transplantation antigens.
Some of the elongated myofibroblast-like cells in the tumour
capsule-granulation tissue stained positive with the ED1, and
occasionally the ED2, macrophage and CD8 antibodies. Fibroblasts
and endothelial cells have been described occasionally to be
positive for ED1 (Damoiseaux et al, 1994). In the normal liver
surrounding the tumour, we found plenty of elongated sinusoidal
cells positive with ED1. The most plausible explanation is that they
are Kupffer cells, but we cannot exclude that some might be
endothelial cells. Perhaps these elongated, ED1-positive cells might
be incorporated into the capsule.
A vaccination effect has been suggested to be important for the
effect of the two chemotherapy models cytosine deaminase/5-
fluorocytosine (Consalvo et al, 1995; Kuriyama et al, 1999b;
Morris, 1999; Pierrefite-Carle et al, 1999) and herpes simplex virus
thymidine kinase/ganciclovir (Barba et al, 1994; Yamamoto et al,
1997; Kuriyama et al, 1999a), and for the effect of photodynamic
therapy (PDT) (Chen et al, 1997; Chen et al, 1999). These
modalities induce tumour cell necrosis, and an inflammatory
microenvironment, which is critical for eliciting an efficient
immune response (Melcher et al, 1998; Todryk et al, 1999; Sauter
et al, 2000). Cell death following irradiation, ‘conventional’
chemotherapy and conventional hyperthermia (p42.51C) is
mainly apoptotic (Cummings et al, 1997), which should give a
less immunogenic response.
There is strong evidence that heat shock proteins (HSPs) are
involved in mediating the immunological response against
tumours. Heat shock protein–tumour peptide complexes are taken
up by antigen-processing cells like macrophages/dendritic cells,
where the tumour peptides are processed and presented to T cells,
eliciting an immune response (Basu et al, 2000; Sauter et al, 2000;
Srivastava, 2002). In our tumour model, ILT causes a shift of HSP70
from the cytoplasm to nucleus in tumour cells, an increase in
tumour-infiltrating macrophages and an increase of HSP70 in ED1-
positive macrophages (Ivarsson et al, 2003). It has been shown that
necrotic, but not apoptotic, cell death can cause the release of HSPs
(Basu et al, 2000; Sauter et al, 2000; Srivastava, 2002).
The reason why we use the low temperature of 461C 3mm from
the tumour margin (during 30min) is that we want to obtain cell
death that develops into necrosis within a time range of hours to a
few days (Wheatley et al, 1989). It is important that there is no
coagulation of protein at this temperature level, which means that
undestroyed tumour antigens can be exposed to the immune
system. Furthermore, at this temperature, tumour blood flow is not
abolished (Sturesson et al, 2005). Nevertheless, the ILT method
produces complete necrosis of treated tumour (Mo ¨ller et al, 1997,
1998; Tranberg et al, 2002).
In conclusion, laser thermotherapy appears to be a promising
method for curative treatment of solid tumours. Hyperthermia
may play an important role in immunotherapeutic approaches in
the future.
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